Zhejiang Tianyu Pharmaceut (300702.SZ) traded flat 0 % during a 24 hours period ending at 12:31 AM Central Europe on Tuesday 27th. One Zhejiang Tianyu Pharmaceut stock can currently be bought for about CNY 20.33 on popular exchanges. Current supply of Zhejiang Tianyu Pharmaceut stocks is 345.1 mn. Zhejiang Tianyu Pharmaceut has a current market capitalization of CNY 6.9 bn and approximately CNY 60.3 mn worth of Zhejiang Tianyu Pharmaceut was traded on exchanges in the last 24 hours. Since last month end, Zhejiang Tianyu Pharmaceut has traded -5.73 % down. Simple moving average of last 200 days is at CNY 20.89. The highest price of past 52 weeks was recorded at CNY 27.8 on 11/14/2025. 52 weeks low was at CNY 17.98 on 06/04/2026.

Here is how related stocks have performed in the past 24 hours:

  • Chongqing Lummy Phar (300006.SZ) traded flat 0 % and now trades at CNY 8.85. Current market capitalisation for Chongqing Lummy Phar is CNY 8.3 bn.

  • China East Education (0667.HK) traded up 6.4 % and now trades at HKD 4.34. Current market capitalisation for China East Education is HKD 9.8 bn. China East Education has a current price to earnings ratio of 8.54.

  • Ruifeng Power (2025.HK) traded down -2.56 % and now trades at HKD 12.45. Ruifeng Power has a market capitalisation of HKD 9.8 bn. Ruifeng Power has a current price to earnings ratio of 388.27.

  • Yunnan Energy Investment C (002053.SZ) traded flat 0 % and now trades at CNY 9.08. Yunnan Energy Investment C has a market capitalisation of CNY 1.1 bn. Current price/earnings ratio for Yunnan Energy Investment C is 35.59.

  • Sichuan 6912 Communication (301592.SZ) traded flat 0 % and now trades at CNY 117.8. Current market capitalisation for Sichuan 6912 Communication is CNY 8.3 bn.

About Zhejiang Tianyu Pharmaceut

Zhejiang Tianyu Pharmaceutical Co., Ltd. is a health care company operating in the pharmaceutical intermediate and API sector. They are based in Taizhou, China, and their operations include research, development, manufacturing, and selling of their products both domestically and internationally. They specialize in cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series of pharmaceutical intermediates and APIs. The company was founded in 1993 and is publicly traded at the Shenzhen Stock Exchange. Their website is www.tianyupharm.com .